PP 2.6 – 00043 Probing cell death pathways in response to NNRTI treatment using a THP-1 infection model

PP 2.6 – 00043 Probing cell death pathways in response to NNRTI treatment using a THP-1 infection model

Bibliographic Details
Main Authors:	P. Zuck, Z. Fang, B. Howell, U.M. Lim, C. Balibar
Format:	Article
Language:	English
Published:	Elsevier 2022-12-01
Series:	Journal of Virus Eradication
Online Access:	http://www.sciencedirect.com/science/article/pii/S2055664022001005

Similar Items

PP 2.2 – 00024 Evaluation of an NNRTI-mediated Targeted Activated Cell Kill (TACK) in a Viremic Mouse Model
by: J. Maxwell, et al.
Published: (2022-12-01)

NNRTI and Liver Damage: Evidence of Their Association and the Mechanisms Involved
by: Ana M. Benedicto, et al.
Published: (2021-07-01)

Multiple dosage forms of the NNRTI microbicide dapivirine: product development and evaluation
by: Romano Joseph
Published: (2006-12-01)

NNRTI-associated mutations in patients with virologic failure on first-line regimen in Yekaterinburg
by: A. Chuykov, et al.
Published: (2014-04-01)

NNRTI-induced HIV-1 protease-mediated cytotoxicity induces rapid death of CD4 T cells during productive infection and latency reversal
by: Benjamin Trinité, et al.
Published: (2019-06-01)

Valutazione del turn over dei farmaci antiretrovirali in particolare da IP a NNRTI
by: Sergio Sabbatani, et al.
Published: (2003-03-01)

Identification of the critical sites of NNRTI-resistance in reverse transcriptase of HIV-1 CRF_BC strains.
by: Yang Huang, et al.
Published: (2014-01-01)

Soluble CD26/Dipeptidyl Peptidase IV Enhances the Transcription of IL-6 and TNF-α in THP-1 Cells and Monocytes.
by: Tetsurou Ikeda, et al.
Published: (2013-01-01)

PP 1.14 – 00094 Development of an immunocytochemistry assay to quantify the translationally active HIV reservoir
by: G. Wu, et al.
Published: (2022-12-01)

Emergency of primary NNRTI resistance mutations without antiretroviral selective pressure in a HAART-treated child
by: Machado, E, et al.
Published: (2009)

Cost-effectiveness of early treatment with first-line NNRTI-based HAART regimens in the UK, 1996-2006.
by: Eduard J Beck, et al.
Published: (2011-01-01)

Renal impairment after switching from stavudine/lamivudine to tenofovir/lamivudine in NNRTI-based antiretroviral regimens
by: Suntisuklappon Busakorn, et al.
Published: (2010-10-01)

Emergence of primary NNRTI resistance mutations without antiretroviral selective pressure in a HAART-treated child.
by: Elizabeth S Machado, et al.
Published: (2009-01-01)

Low-Frequency NNRTI-Resistant HIV-1 Variants and Relationship to Mutational Load in Antiretroviral-Naïve Subjects
by: Shaili Gupta, et al.
Published: (2014-09-01)

Immunologic and virologic failure after first-line NNRTI-based antiretroviral therapy in Thai HIV-infected children
by: Phasomsap Chayapa, et al.
Published: (2011-10-01)

High Prevalence of Doravirine Resistance in HIV-1-Infected Patients with Virological Failure to an NNRTI-Based Single-Tablet Regimen
by: Tsai HC, et al.
Published: (2022-07-01)

Early virological suppression despite high frequency NNRTI resistance following perinatal prophylaxis in HIV-infected African infants
by: Coovadia Hoosen, et al.
Published: (2008-04-01)

Not all missed doses are the same: sustained NNRTI treatment interruptions predict HIV rebound at low-to-moderate adherence levels.
by: Jean-Jacques Parienti, et al.
Published: (2008-07-01)

PLACENTAL SECRETORY FACTORS INFLUENCE TO THP-1 CELLS PHENOTYPE AND THP-1 CELLS TRANSENDOTHELIAL MIGRATION
by: O. I. Stepanova, et al.
Published: (2014-07-01)

The effects of ART on the dynamics of lipid profiles in Chinese Han HIV-infected patients: comparison between NRTI/NNRTI and NRTI/INSTI
by: Shengnan Liu, et al.
Published: (2023-04-01)

Caspase-8 Potentiates Triglyceride (TG)-Induced Cell Death of THP-1 Macrophages via a Positive Feedback Loop
by: Byung Chul Jung, et al.
Published: (2021-06-01)

TRIBOLOGICAL IMPLICATIONS OF THP MODULARIZATION
by: Lucian CAPITANU, et al.
Published: (2019-06-01)

Euphorbia formosana Root Extract Induces Apoptosis by Caspase-Dependent Cell Death via Fas and Mitochondrial Pathway in THP-1 Human Leukemic Cells
by: Yann-Lii Leu, et al.
Published: (2013-02-01)

Raltegravir, tenofovir, and emtricitabine in an HIV-Infected patient with HCV chronic hepatitis, NNRTI intolerance and protease inhibitors-induced severe liver Toxicity
by: Ortu F, et al.
Published: (2010-02-01)

High rates of transmitted NNRTI resistance among persons with acute HIV infection in Malawi: implications for first-line dolutegravir scale-up
by: Sarah E. Rutstein, et al.
Published: (2019-02-01)

The impact of choice of NNRTI on short-term treatment outcomes among HIV-infected patients prescribed tenofovir and lamivudine in Johannesburg, South Africa.
by: Kate Shearer, et al.
Published: (2013-01-01)

Long-term treatment outcomes of ritonavir-boosted lopinavir monotherapy among HIV-infected patients who experienced NRTI and NNRTI failure
by: Manosuthi Weerawat, et al.
Published: (2012-03-01)

Treatment outcomes and plasma level of ritonavir-boosted lopinavir monotherapy among HIV-infected patients who had NRTI and NNRTI failure
by: Nilkamhang Samruay, et al.
Published: (2009-12-01)

Sweet Bee Venom Triggers Multiple Cell Death Pathways or Spurs Acute Cell Rupture According to Its Concentration in THP-1 Monocytic Leukemia Cells
by: Jae-Min Ryu, et al.
Published: (2022-01-01)

Long‐term outcomes of rapid antiretroviral NNRTI‐based initiation among Thai youth living with HIV: a national registry database study
by: Sirinya Teeraananchai, et al.
Published: (2023-03-01)

Virtual screening, molecular docking studies and DFT calculations of FDA approved compounds similar to the non-nucleoside reverse transcriptase inhibitor (NNRTI) efavirenz
by: Maryam A. Jordaan, et al.
Published: (2020-08-01)

Adiponectin and the steatosis marker Chi3L1 decrease following switch to raltegravir compared to continued PI/NNRTI-based antiretroviral therapy.
by: Obiageli Offor, et al.
Published: (2018-01-01)

Extracellular vesicles from serum samples of mycobacteria patients induced cell death of THP-1 monocyte and PBMC
by: Alireza Javadi, et al.
Published: (2022-02-01)

NHS-Functionalized THP Derivative for Efficient Synthesis of Kit-Based Precursors for <sup>68</sup>Ga Labeled PET Probes
by: Giuseppe Floresta, et al.
Published: (2021-04-01)

Peptides Regulating Proliferative Activity and Inflammatory Pathways in the Monocyte/Macrophage THP-1 Cell Line
by: Francesco Avolio, et al.
Published: (2022-03-01)

HIV drug resistance mutations in non-B subtypes after prolonged virological failure on NNRTI-based first-line regimens in sub-Saharan Africa
by: Kityo, C, et al.
Published: (2017)

POSITION-SENSITIVE ATOM-PROBE STUDY OF THE DECOMPOSITION OF A CU-2.6AT-PERCENT-CO ALLOY
by: Setna, R, et al.
Published: (1993)

FHL2 regulates THP-1 macrophage foaming through NF-κB signaling pathway
by: CHEN Weiwei, LIAO Huang, SHI Zhenhong, LUO Ying
Published: (2024-02-01)

The SIRT2 Pathway Is Involved in the Antiproliferative Effect of Flavanones in Human Leukemia Monocytic THP-1 Cells
by: Caterina Russo, et al.
Published: (2022-09-01)

Sporothrix globosa melanin regulates autophagy via the TLR2 signaling pathway in THP-1 macrophages.
by: Mengqi Guan, et al.
Published: (2023-05-01)